KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
83 hedge funds and large institutions have $118M invested in Kindred Biosciences, Inc. in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+6
Holders Change %
+7.79%
% of All Funds
1.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
36
Reduced
16
Closed
11
Calls
$534K
Puts
$1K
Net Calls
+$533K
Net Calls Change
+$523K
Top Buyers
| 1 |
1
Ameriprise
Minneapolis,
Minnesota
|
$8.75M |
| 2 |
2
Millennium Management
New York
|
$3.69M |
| 3 |
3
Renaissance Technologies
New York
|
$6.22M |
| 4 |
4
Wells Fargo
San Francisco,
California
|
$1.33M |
| 5 |
HP
5
Hound Partners
New York
|
$359K |
